• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Smartsheet, Kroger, Lantronix And Other Big Stocks Moving Higher On Friday

    9/8/23 10:29:09 AM ET
    $ACRS
    $CBAY
    $GATO
    $GWRE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACRS alert in real time by email

    U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.

    Lantronix, Inc. (NASDAQ:LTRX) shares jumped 26.3% to $5.05 following better-than-expected quarterly sales.

    Smartsheet Inc. (NASDAQ:SMAR) rose 14.1% to $46.04 after the company reported a second-quarter earnings beat and issued strong guidance.

    Smith & Wesson Brands, Inc. (NASDAQ:SWBI) shares gained 13.5% to $11.94 after the company reported better-than-expected financial results.

    Gatos Silver, Inc. (NYSE:GATO) jumped 13% to $5.25. Canaccord Genuity upgraded Gatos Silver from Hold to Buy and raised the price target from $5 to $5.5.

    Guidewire Software, Inc. (NYSE:GWRE) surged 12.2% to $95.23 following quarterly results.

    CymaBay Therapeutics, Inc. (NASDAQ:CBAY) jumped 11.1% to $16.67. Raymond James maintained CymaBay Therapeutics with a Strong Buy and raised the price target from $17 to $33.

    Seneca Foods Corporation (NASDAQ:SENEA) gained 7.8% to $53.50.

    IonQ, Inc. (NYSE:IONQ) jumped 7.1% to $18.68.

    Lifezone Metals Limited (NYSE:LZM) rose 7.1% to $13.13.

    Aclaris Therapeutics, Inc. (NASDAQ:ACRS) surged 7% to $8.06.

    STAAR Surgical Company (NASDAQ:STAA) gained 7% to $45.13. STAAR Surgical 10% owner Neal Bradsher acquired a total of 189,962 shares an average price of $41.42.

    Precision Drilling Corporation (NYSE:PDS) jumped 5.8% to $72.65.

    The Kroger Co. (NYSE:KR) rose 4% to $47.22 following quarterly results. The company also reached an opioid settlement agreement, agreeing to pay up to $1.2 billion to states and subdivisions and $36 million to tribes.

    Now Read This: Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 3% Dividend Yields

    Get the next $ACRS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRS
    $CBAY
    $GATO
    $GWRE

    CompanyDatePrice TargetRatingAnalyst
    STAAR Surgical Company
    $STAA
    2/3/2026$26.00Neutral
    Wedbush
    STAAR Surgical Company
    $STAA
    1/16/2026$13.00Underweight
    Morgan Stanley
    Kroger Company
    $KR
    1/8/2026$75.00Hold → Buy
    Deutsche Bank
    IonQ Inc.
    $IONQ
    12/17/2025$60.00Outperform
    Wedbush
    Guidewire Software Inc.
    $GWRE
    12/17/2025$250.00Neutral → Buy
    DA Davidson
    IonQ Inc.
    $IONQ
    12/16/2025$100.00Buy
    Jefferies
    IonQ Inc.
    $IONQ
    12/11/2025$90.00Outperform
    Mizuho
    Kroger Company
    $KR
    12/5/2025$82.00 → $80.00Outperform
    Telsey Advisory Group
    More analyst ratings

    $ACRS
    $CBAY
    $GATO
    $GWRE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Broadwood Partners, L.P. bought $606,138 worth of shares (27,485 units at $22.05) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    1/13/26 9:30:12 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Large owner Broadwood Partners, L.P. bought $8,817,664 worth of shares (406,653 units at $21.68) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    1/8/26 7:31:31 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Large owner Broadwood Partners, L.P. bought $41,060,317 worth of shares (1,500,000 units at $27.37) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    11/21/25 9:55:23 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    $ACRS
    $CBAY
    $GATO
    $GWRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Savings Programs that offer Affordable Access to GLP-1s Available at Kroger

    Paired with nutrition support, fresh food and easy access to dietitians, Kroger can help customers reach wellness goalsCINCINNATI, Feb. 24, 2026 /PRNewswire/ -- The Kroger Co. family of companies and its pharmacies ("Kroger") (NYSE:KR) participates in several savings programs, including those from pharmaceutical manufacturers, which may reduce eligible customers' cost of filling certain GLP-1 medications. Combined with Kroger's broad selection of fresh foods, protein‑rich options and personalized support from registered dietitians, the company offers a convenient, holistic approach to helping customers achieve their wellness goals.

    2/24/26 11:40:00 AM ET
    $KR
    Food Chains
    Consumer Staples

    Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052

    WAYNE, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has initiated a placebo-controlled Phase 1b proof-of-concept (POC) trial of ATI-052, the Company's potential best-in-class investigational bispecific anti-TSLP/IL-4Rα antibody, in asthma. This announcement follows the recent initiation of the Company's Phase 1b POC trial of ATI-052 in atopic dermatitis (AD). Planning is ongoing for a Phase 2b program encompassing asthma and atopic dermatitis as potential first indications. The Company expects to initiate thi

    2/24/26 7:00:00 AM ET
    $ACRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IonQ Selected to Support Missile Defense Agency SHIELD IDIQ Contract

    IonQ (NYSE:IONQ) is pleased to announce it was awarded a contract under the Missile Defense Agency Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) indefinite-delivery/indefinite-quantity (IDIQ) contract with a ceiling of $151 billion. This contract encompasses a broad range of work areas that allows for the rapid delivery of innovative capabilities to the warfighter with increased speed and agility. IonQ is among more than 2,400 companies eligible to compete for future task orders issued under the SHIELD IDIQ contract framework. IonQ delivers a full portfolio of quantum technologies spanning quantum computing, quantum networking, quantum sensing, and quantum security. T

    2/23/26 4:30:00 PM ET
    $IONQ
    EDP Services
    Technology

    $ACRS
    $CBAY
    $GATO
    $GWRE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIVDELZI issued to CYMABAY THERAPEUTICS INC

    Submission status for CYMABAY THERAPEUTICS INC's drug LIVDELZI (ORIG-1) with active ingredient SELADELPAR has changed to 'Approval' on 08/14/2024. Application Category: NDA, Application Number: 217899, Application Classification: Type 1 - New Molecular Entity

    8/14/24 12:53:53 PM ET
    $CBAY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRS
    $CBAY
    $GATO
    $GWRE
    SEC Filings

    View All

    SEC Form 6-K filed by Precision Drilling Corporation

    6-K - PRECISION DRILLING Corp (0001013605) (Filer)

    2/24/26 4:49:29 PM ET
    $PDS
    Oil & Gas Production
    Energy

    SEC Form 144 filed by IonQ Inc.

    144 - IonQ, Inc. (0001824920) (Subject)

    2/24/26 4:31:21 PM ET
    $IONQ
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Guidewire Software Inc.

    SCHEDULE 13G/A - Guidewire Software, Inc. (0001528396) (Subject)

    2/17/26 4:19:02 PM ET
    $GWRE
    Computer Software: Prepackaged Software
    Technology

    $ACRS
    $CBAY
    $GATO
    $GWRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Rosenbaum Michael George sold $150,600 worth of shares (1,200 units at $125.50), decreasing direct ownership by 0.52% to 229,543 units (SEC Form 4)

    4 - Guidewire Software, Inc. (0001528396) (Issuer)

    2/23/26 5:32:17 PM ET
    $GWRE
    Computer Software: Prepackaged Software
    Technology

    President and CEO De Masi Niccolo was granted 11,556 shares, increasing direct ownership by 0.99% to 1,176,452 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/20/26 9:55:04 PM ET
    $IONQ
    EDP Services
    Technology

    CFO & COO Singh Inder M was granted 3,708 shares, increasing direct ownership by 0.87% to 431,909 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/20/26 9:55:03 PM ET
    $IONQ
    EDP Services
    Technology

    $ACRS
    $CBAY
    $GATO
    $GWRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wedbush initiated coverage on STAAR Surgical with a new price target

    Wedbush initiated coverage of STAAR Surgical with a rating of Neutral and set a new price target of $26.00

    2/3/26 8:08:13 AM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Morgan Stanley resumed coverage on STAAR Surgical with a new price target

    Morgan Stanley resumed coverage of STAAR Surgical with a rating of Underweight and set a new price target of $13.00

    1/16/26 8:34:38 AM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Kroger upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Kroger from Hold to Buy and set a new price target of $75.00

    1/8/26 8:23:53 AM ET
    $KR
    Food Chains
    Consumer Staples

    $ACRS
    $CBAY
    $GATO
    $GWRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Aclaris Therapeutics Inc.

    SC 13G - Aclaris Therapeutics, Inc. (0001557746) (Subject)

    11/25/24 11:02:19 AM ET
    $ACRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Aclaris Therapeutics Inc.

    SC 13G - Aclaris Therapeutics, Inc. (0001557746) (Subject)

    11/22/24 4:00:23 PM ET
    $ACRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Aclaris Therapeutics Inc.

    SC 13G - Aclaris Therapeutics, Inc. (0001557746) (Subject)

    11/21/24 4:51:50 PM ET
    $ACRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRS
    $CBAY
    $GATO
    $GWRE
    Financials

    Live finance-specific insights

    View All

    STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results for the fourth quarter and fiscal year ended January 2, 2026, on Tuesday, March 3 after the market close. The Company will also host an earnings call and webcast at 5:30 p.m. ET to discuss its financial results and business progress. Event: STAAR Surgical Fourth Quarter and Fiscal Year 2025 Financial Results Webcast Date: Tuesday, March 3, 2026 Time: 5:30 p.m. ET/ 2:30 p.m. PT Location: https://event.choruscall.com/mediaframe/webcast.html?webcastid=J3bNAuVd Topics on the c

    2/23/26 4:01:00 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Guidewire to Announce Second Quarter Fiscal Year 2026 Financial Results on March 5, 2026

    Guidewire (NYSE:GWRE) announced that it will release its financial results for the fiscal quarter ended January 31, 2026 after market close on Thursday, March 5, 2026. On that day, management will host an audio webcast at 2:00 p.m. PT (5:00 p.m. ET) to review and discuss the Company's results for the second quarter fiscal year 2026. The live audio webcast will be accessible to the public through the Investor Relations website at https://ir.guidewire.com/. A replay of the webcast will be available two hours after the conclusion of the live event and archived for a period of three months. What: Guidewire Second Quarter Fiscal Year 2026 Financial Results Conference Call When

    2/19/26 4:15:00 PM ET
    $GWRE
    Computer Software: Prepackaged Software
    Technology

    Quantum Speed Technology Targeting Multi-Trillion-Dollar Infrastructure Efficiency Opportunity

    Advanced computing power positions companies to unlock cost savings across global energy, transportation, and logistics networksNEW YORK, Feb. 17, 2026 /CNW/ -- Market News Updates News Commentary - Quantum speed is all about solving really big problems much faster than traditional computers. For large-scale infrastructure -- think power grids, transportation systems, or supply chains -- there are millions of data points and interconnected moving parts. Classical computers can tackle this complexity, but it often takes a long time. Quantum-powered systems, by contrast, can evaluate many possibilities at once, helping planners and operators find smarter solutions in a fraction of the time. Th

    2/17/26 9:00:00 AM ET
    $IONQ
    $LAZR
    $QBTS
    EDP Services
    Technology
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ACRS
    $CBAY
    $GATO
    $GWRE
    Leadership Updates

    Live Leadership Updates

    View All

    Kroger Appoints Greg Foran as Chief Executive Officer

    Accomplished Food Retail Leader Brings Strong Experience as Company Advances Its Growth Strategy Ron Sargent Continues as Chairman of Kroger's Board of Directors  CINCINNATI, Feb. 9, 2026 /PRNewswire/ -- The Kroger Co. (NYSE:KR) today announced its Board of Directors appointed Greg Foran as Chief Executive Officer, effective immediately. Foran will also join Kroger's Board of Directors and succeeds Ron Sargent, who served as interim CEO since March 2025. This announcement follows an extensive search process conducted by the Board to identify an innovative retail leader with a strong track record of execution at scale.

    2/9/26 7:30:00 AM ET
    $KR
    Food Chains
    Consumer Staples

    Corinex Appoints George Reznik as Chief Operating Officer to Accelerate Global Expansion

    VANCOUVER, BC, Feb. 2, 2026 /PRNewswire/ - Corinex, a global leader in Broadband-over-Power-Line (BPL) technology, announced the appointment of George Reznik as Chief Operating Officer. Mr. Reznik is an entrepreneurial, operational, and strategic executive leader. He has a track record of growing top-line revenue, bottom-line performance, and market share while building, commercializing, and scaling global technology companies.Corinex is accelerating the transformation of electricity networks, turning existing power line infrastructure into high-capacity, secure communications networks. This helps utilities accelerate grid modernization, integrate low-carbon technologies at scale, and increa

    2/2/26 12:30:00 PM ET
    $LTRX
    Computer Communications Equipment
    Telecommunications

    STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs

    Search Committee Has Initiated a Global Search to Select Next CEO STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors (the "Board") has appointed Warren Foust, President and Chief Operating Officer, and Deborah Andrews, Chief Financial Officer, as interim co-Chief Executive Officers, effective February 1, 2026. Mr. Foust and Ms. Andrews will work together with the other members of the executive leadership team, with support and guidance from the Board, as they lead the Company and manage its day-to-day operations.

    2/2/26 7:00:00 AM ET
    $STAA
    Ophthalmic Goods
    Health Care